WHO ICTRP trial
Trial of high flow nasal prong (HFNP) oxygen therapy for viral bronchiolitis in…
ACTRN12611001016921 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12611001016921 |
|---|---|
| Public title | Trial of high flow nasal prong (HFNP) oxygen therapy for viral bronchiolitis in children's wards of south-west Sydney. |
| Scientific title | The effect of high flow nasal prong oxygen therapy versus standard care on rate of intubation and requirements for intensive care in children with viral bronchiolitis |
| Primary sponsor | Prof John Whitehall |
| Secondary sponsors | University of Western Sydney |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Bronchiolitis; Bronchiolitis;Respiratory - Other respiratory disorders / diseases |
| Interventions | High flow nasal prong therapy Children with viral bronchiolitis requiring more than 2L/min oxygen will receive treatment as per protocol A (Control) or B (Treatment) Protocol B: -Patient given HFNP providing humidified and warmed to 37… |
| Registration date | Sep 21, 2011 |
| Target size | 90 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: